Go to Top

2020 Annual Conference

Register Today: Click Here

If you have already registered and wish to review the program and the sessions that you have registered to attend, Click Here

Thrombosis Canada Program Co-chairs:

Lana Castellucci, MD, FRCPC, MSc and Eric Tseng, MD, MScCH, FRCPC

CanVECTOR Program Co-chairs: 

Eric Tseng, MD, MScCH, FRCPC and Patricia Liaw, BSc, MSc, PhD

MEETING OBJECTIVES

After completing this program, participants will be equipped to:

  • Apply current evidence in the management of patients with thrombotic disease;
  • Manage thrombosis challenges in face-to-face and virtual clinical practice effectively;
  • Describe thrombosis prophylaxis and treatment in patients affected by COVID-19;
  • Implement thrombosis treatment options in a variety of patient populations.

TARGET AUDIENCE

Physicians, nurses and pharmacists involved in the management of patients with challenging medical or surgical conditions requiring personalized anticoagulant management.

ACCREDITATION

This Group Learning program has been reviewed by the College of Family Physicians of Canada and is awaiting final certification by the College’s Ontario Chapter.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Ottawa’s Office of Continuing Professional Development. You may claim a maximum of 11.75 hours (credits are automatically calculated).

Unrestricted support for this program is provided by Alexion Canada, BMS-Pfizer alliance, Bayer Canada, Leo Canada, Pfizer Injectables Canada, Sanofi Canada and Servier Canada.